SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending heavily as the community anticipates major clinical trial milestones and a potential short squeeze, with investors debating the company's valuation and the outcome of the ongoing REGAL trial. Bulls are pointing to high institutional interest and the potential for a buyout, while a vocal group of bears warns of high risk and potential dilution.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant volatility as investors weigh speculative reports of SpaceX's interest in the consumer mobile market against the company's own momentum, including upcoming satellite launches and potential government contract awards. The community is actively debating the competitive landscape and long-term viability of ASTS's partnership-based model versus direct-to-consumer alternatives, with many bulls treating the recent price pullback as a strategic accumulation opportunity.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense market volatility and high trading volume, with the community actively debating whether the price action represents a potential short squeeze or a recurring pump-and-dump cycle. Investors remain divided, with some highlighting the project's potential for rapid recovery while others express concern over liquidity and a perceived lack of developer communication.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is seeing heightened activity as community members debate its aggressive share buyback strategy, institutional ownership levels, and a potential partnership with SpaceX to enhance mobile offerings. While some investors view the stock's significant decline as an undervalued entry point, others remain skeptical, focusing on the company's substantial debt load and stiff competition from satellite internet providers.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is currently a focal point of debate as investors weigh the company's aggressive safety overhauls against the short-term disruption these changes have caused to user engagement and bookings growth. The community remains deeply divided, with some seeing the pullback as a buying opportunity given the stock's strong user base and infrastructure potential, while vocal critics point to ongoing legal pressures and insider selling as reasons to avoid the name.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is facing significant downward pressure, with market participants heavily debating the impact of institutional holdings and potential credit unwinds amidst a broader tech-sector selloff. The community is deeply divided, with some investors aggressively accumulating on dips, while others warn of systemic risks and a continued bear cycle tied to broader economic uncertainty.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing significant market attention following the FDA approval of Lumvoa for thyroid eye disease, with the community actively debating the drug's commercial potential against established competitors like Tepezza. Discussion is heavily focused on the company's immediate launch strategy, the significance of the broad label covering both active and chronic disease, and whether current valuation levels account for this pivotal commercial milestone.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia Corp is trending as investors aggressively position ahead of a critical patent litigation ruling, with strong bullish sentiment fueled by robust adoption metrics for its Yutrepia product. Community discussion remains heavily focused on the stock's massive long-term outperformance compared to peers and speculation that a favorable court decision could trigger significant upside or an acquisition.

Tidal Trust II - Defiance Daily Target 2x Long MSTR ETF

Defiance Daily Target 2x Long MSTR ETF

MSTX is experiencing significant volatility as traders debate whether to capitalize on amplified price swings through the 2x leveraged ETF or avoid it due to concerns over decay and potential reverse splits. Community sentiment is deeply divided between those aggressively accumulating positions in anticipation of a massive rebound in MicroStrategy and those warning that the instrument is a structural trap for long-term holders.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following an unprecedented price hike across its Mac, iPad, and Vision Pro product lines, which the company attributed to surging high-bandwidth memory and storage costs driven by AI data center demand. While some community members view these price adjustments as a necessary move to protect margins, many investors and traders are actively debating whether this signals potential demand destruction and if the company's premium brand loyalty is strong enough to absorb these rising costs.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TNYA 
New FINRA short interest data dropped today. 28.6M shares short(76% of the 37.5M series b warrants) with 8.4 days to cover. I think it is safe to say that the price action we&#39;ve seen on the recent good news was  the result of mechanical arbitrage and has no bearing on the scientific merits of this company. Three more trading days until expiration 🤑  
- When a short position only grows in lockstep with the birth of new warrants, it&#39;s because the institutions buying the warrants are immediately shorting the stock against them to lock in their risk-free spreads. 
- The fact that the stock has been relentlessly &quot;glued&quot; to the $0.71–$0 .73 range on incredibly low volume right before expiration is a classic sign of market-maker stabilization, not directional aggressive shorting. 
- If a small-cap biotech stock had nearly 30 million shares of organic short interest, the CTB would usually skyrocket into the triple digits because shares would be incredibly scarce to find.

mohit vora

Rolfthewild

WEI HAO

Daniel Gyldenås

Phoebe Burwell

Jay Rau

eren bugra Ergin

Kenneth

Glikin_mouse

Bryce Milburn

Vikke

Viken Kazarian

Dan Bor

Billy Bob

Karlamarinsek

StockTwits Web

Tenaya Therapeutics Inc

 
New FINRA short interest data dropped today. 28.6M shares short(76% of the 37.5M series b warrants) with 8.4 days to cover. I think it is safe to say that the price action we've seen on the recent good news was  the result of mechanical arbitrage and has no bearing on the scientific merits of this company. Three more trading days until expiration 🤑  
- When a short position only grows in lockstep with the birth of new warrants, it's because the institutions buying the warrants are immediately shorting the stock against them to lock in their risk-free spreads. 
- The fact that the stock has been relentlessly "glued" to the $0.71–$0 .73 range on incredibly low volume right before expiration is a classic sign of market-maker stabilization, not directional aggressive shorting. 
- If a small-cap biotech stock had nearly 30 million shares of organic short interest, the CTB would usually skyrocket into the triple digits because shares would be incredibly scarce to find.

Hank

StockTwits for iOS

@AutisticRetardo  Hmm, when I look at this, the company Regencell Bio keeps coming to mind; if I recall correctly, it languished around the $4 level for three years. More than 80% of the shares were held by either institutional investors or the CEO, and they didn&#39;t sell a thing. Then, thanks to data from a single drug, it shot up to $800 within two weeks—if I remember right—before eventually splitting and settling around the $70 mark. Why couldn&#39;t our stock reach double digits, too? After all, many stocks are held by institutional investors. Let&#39;s see what happens; hopefully, it turns out well.

  Hmm, when I look at this, the company Regencell Bio keeps coming to mind; if I recall correctly, it languished around the $4 level for three years. More than 80% of the shares were held by either institutional investors or the CEO, and they didn't sell a thing. Then, thanks to data from a single drug, it shot up to $800 within two weeks—if I remember right—before eventually splitting and settling around the $70 mark. Why couldn't our stock reach double digits, too? After all, many stocks are held by institutional investors. Let's see what happens; hopefully, it turns out well.

@eren1 imho if you&#39;re willing to hold until TN-101 takes off, $100 is a low ball. that is still a long way off tho

 imho if you're willing to hold until TN-101 takes off, $100 is a low ball. that is still a long way off tho